Here, we took advantage of a genetically well-defined overexpression of NRG1 type III in a transgenic mouse line to evaluate its effects on ALS outcome in a double transgenic NRG1-SOD1G93A mouse model. This evidence concerns the gene NRG1 and amyotrophic lateral sclerosis.